Literature DB >> 24341121

IgG4-related sclerosing disease: an emerging entity frequently misdiagnosed.

Roberta Mazzucchelli1, Stefano Racchini2, Francesca Barbisan2, Andrea B Galosi3, Sara Giorgini2.   

Abstract

IgG4-related sclerosing disease, a multiorgan system disease that has been identified in the last 10 years, is a fibroinflammatory condition with a marked propensity to manifest itself as mass forming lesions characterized by three main histological features (sclerosis, obliterative phlebitis and lymphoplasmacytic infiltrate) and by the presence of abundant IgG4+ plasma cells, frequent elevation of serum IgG4 and a dramatic initial response to steroid therapy. The aim of this mini-review is to increase the capacity to identify the characteristic features of IgG4-related sclerosing disease in specific organs and in two newly proposed entities (urethral caruncle and paratesticular fibrous pseudotumor) using biopsy specimens and methods of counting IgG4. In addition we examine the relationship between IgG4-related sclerosing disease and malignancy. In fact, an increased ability to recognize the characteristic features of IgG4-related sclerosing disease would play an extremely important role in avoiding unnecessary surgery in favor of initiating corticosteroid therapy.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24341121

Source DB:  PubMed          Journal:  Anal Quant Cytopathol Histpathol        ISSN: 2578-742X


  2 in total

1.  Focal autoimmune pancreatitis and chronic sclerosing sialadenitis mimicking pancreatic cancer and neck metastasis.

Authors:  Li Sun; Qiang Zhou; David R Brigstock; Su Yan; Ming Xiu; Rong-Li Piao; Yan-Hang Gao; Run-Ping Gao
Journal:  World J Gastroenterol       Date:  2014-12-14       Impact factor: 5.742

2.  IgG4-related inflammatory pseudotumor of the renal pelvis involving renal parenchyma, mimicking malignancy.

Authors:  Ho Gyun Park; Kyoung Min Kim
Journal:  Diagn Pathol       Date:  2016-01-22       Impact factor: 2.644

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.